FDA grants IND clearance for ovarian cancer trial of Oncoinvent

FDA grants IND clearance for ovarian cancer trial of Oncoinvent

Submitted by admin on November 1, 2023 - 10:12am
Source: 
Clinical Trials Arena
News Tags: 
Oncoinvent
FDA
Radspherin
ovarian cancer
Headline: 
FDA grants IND clearance for ovarian cancer trial of Oncoinvent
snippet: 

The US FDA has granted IND clearance for Oncoinvent's Phase II trial of Radspherin for ovarian cancer associated peritoneal carcinomatosis.

Do Not Allow Advertisers to Use My Personal information